The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Vaccines for the 21st Century: A Tool for Decisionmaking
Table A3–1 Incidence and Mortality Rates for Coccidioides
5-year Age Groups
Total Population
Incidence Rates (per 100,000) (5-year age groups)
Cases
0–4
20,182,000
0.00
0
5–9
19,117,000
0.00
0
10–14
18,939,000
57.73
10,934
15–19
17,790,000
57.73
10,270
20–24
18,473,000
57.73
10,665
25–29
19,294,000
57.73
11,139
30–34
22,376,000
57.73
12,918
35–39
22,215,000
57.73
12,825
40–44
19,934,000
57.73
11,508
45–49
16,873,000
57.73
9,741
50–54
13,351,000
14.65
1,956
55–59
11,050,000
14.65
1,619
60–64
10,191,000
14.65
1,493
65–69
10,099,000
14.65
1,480
70–74
8,865,000
14.65
1,299
75–79
6,669,000
14.65
977
80–84
4,419,000
14.65
648
85+
3,598,000
14.65
527
Total
263,435,000
100,000
Age Groups
Population
Mortality Rates (per 100,000)
% Distribution of Deaths
<1
3,963,000
0.000
0.000
1–4
16,219,000
0.000
0.000
5–14
38,056,000
0.003
0.009
15–24
36,263,000
0.019
0.058
25–34
41,670,000
0.039
0.139
35–44
42,149,000
0.030
0.109
45–54
30,224,000
0.054
0.139
55–64
21,241,000
0.064
0.115
65–74
18,964,000
0.148
0.239
75–84
11,088,000
0.147
0.139
85+
3,598,000
0.181
0.055
Total
263,435,000
0.045
1.0000
with HIV/AIDS. Consideration of this population would result in differences in the calculations achieved with this model, but the uncertainties associated with doing so were thought to be quite extreme.
